Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (ADAPT-teleMG)

NCT05917184 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05917184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05917184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (ADAPT-teleMG)
Lead sponsor
Yale University
Phase
Observational
Overall status
Completed
Start date
August 30, 2021
Completion date
January 20, 2023
Enrollment
52 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

myasthenia gravis